Arunabh Choudhury

Arunabh Choudhury

Auto-generated profile, based on publicly available information

Arunabh Choudhury

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
ACArunabh Choudhury
Arunabh Choudhury
SKSumaiya Khan
Sumaiya Khan
MSMohammad Umar Saeed
Mohammad Umar Saeed
TMTaj Mohammad
Taj Mohammad
AHAfzal Hussain
Afzal Hussain
Md. Imtaiyaz HassanMd. Imtaiyaz Hassan
Md. Imtaiyaz Hassan

11 November 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
AAAnam Ashraf
Anam Ashraf
ACArunabh Choudhury
Arunabh Choudhury
MKMohammad Ali Khan
Mohammad Ali Khan
BABader S. Alotaibi
Bader S. Alotaibi
SNSaba Noor
Saba Noor
Md. Imtaiyaz HassanMd. Imtaiyaz Hassan
Md. Imtaiyaz Hassan

28 January 2026 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
AAAnam Ashraf
Anam Ashraf
MKMohammad Ali Khan
Mohammad Ali Khan
ACArunabh Choudhury
Arunabh Choudhury
SKSwati Kumari
Swati Kumari
BABADER Saud ALOTAIBI
BADER Saud ALOTAIBI
Md. Imtaiyaz HassanMd. Imtaiyaz Hassan
Md. Imtaiyaz Hassan
The escalating crisis of antimicrobial resistance (AMR) among Gram-negative pathogens, particularly Klebsiella pneumoniae (KP), necessitates innovative strategies to enhance the efficacy of existing antibiotics. Synergistic drug combinations present a promising approach to improve therapeutic outcomes and delay the emergence of resistance. This study investigates the synergistic interaction between the natural alkaloid berberine chloride and the repurposed antibiotic rifaximin against KP. Integrated in vitro and in silico analyses reveal significant bactericidal synergy between the two agents, mediated through concurrent inhibition of the transcriptional anti-termination factor RfaH, a key regulator of virulence and capsule biosynthesis. Molecular docking and dynamics simulations demonstrate that both compounds cooperatively bind to the RfaH pocket, stabilizing an inactive ternary complex without major structural disruption. Functional assays confirm that the combination effectively suppresses RfaH-dependent capsule production at lower concentrations compared to monotherapy. These findings suggest that RfaH is a viable target for combinatorial inhibition and provide a plausible mechanistic foundation for the berberine–rifaximin synergy. This work supports the rational development of dual-targeting anti-virulence strategies to combat multidrug-resistant KP infections.

12 April 2026 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
ASAsfiya
Asfiya
SPSneh Prabha
Sneh Prabha
ACArunabh Choudhury
Arunabh Choudhury
Abdelbaset Mohamed ElasbaliAbdelbaset Mohamed Elasbali
Abdelbaset Mohamed Elasbali
AHAfzal Hussain
Afzal Hussain
Md. Imtaiyaz HassanMd. Imtaiyaz Hassan
Md. Imtaiyaz Hassan

22 October 2026 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MSMohammad Umar Saeed
Mohammad Umar Saeed
ACArunabh Choudhury
Arunabh Choudhury
YMYash Mathur
Yash Mathur
Md. Imtaiyaz HassanMd. Imtaiyaz Hassan
Md. Imtaiyaz Hassan